Grant: Engage Grants Program
University of British Columbia
$24,925.00
DNA purification and separation using a prototype digital microfluidic device
FY 2011-12
Summary
Aurora Biomed Inc. is a Canadian company covering a wide global market in environmental, life and health
science research laboratory equipment and technologies. While the company's current products span over a
wide variety of biotechnology applications including automated liquid handling systems, ion channel
technology, and robotic systems for high-throughput and low-cost screening services, Aurora Biomed Inc. is
researching novel technologies to expand and improve its products in response to the increased demand and
technical requirements of today's modern laboratories. Specifically, the VERSATM GENE is a bench-top
workstation equipped with advanced robotic features and high precision liquid handling capabilities designed
to perform nucleic acid purification and polymerase chain reaction (PCR) with high throughput and accuracy.
This system is capable of complete work-up of RNA or DNA samples from extraction to preparation of the
PCR plate for amplification, allowing researchers to overcome nucleic acid extraction bottlenecks. Since the advent of microfluidics research and its numerous successful applications, there has been an increased thrust towards microdevices as alternatives for bench-top scale equipment traditionally used for clinical and forensic diagnostics. The main drivers for this trend are miniaturization, reduced time and cost, high throughput, and greater reliability of results. The addition of a microscale DNA purification device into the product line will be a tremendous competitive edge for Aurora Biomed Inc. The proposed research will provide a proof-of-concept microfluidic prototype for DNA purification and separation. This research will involve the development of a microscale DNA extraction, purification and separation system. Specifically, a digital microfluidic device capable of handling and manipulation of sample droplets having volumes in the range of tens of picoliter to a few hundred nanoliter will be designed, fabricated and tested. This research will be a steppingstone towards long-term collaboration between Aurora Biomed and the applicant in the development of digital microfluidic systems for point-of-care diagnosis and drug discovery applications.
Program
Engage Grants Program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
419415-2011
Name nom
Najjaran, Homayoun
Department département
Okanagan - Engineering, School of
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
24925
Program id
EGP
Program nane en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1100
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Health, education and social services
Area of application fr
Santé publique, éducation et services sociaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
DNA purification and separation using a prototype digital microfluidic device
Keyword
NSERC
Application summary
Aurora Biomed Inc. is a Canadian company covering a wide global market in environmental, life and health
science research laboratory equipment and technologies. While the company's current products span over a
wide variety of biotechnology applications including automated liquid handling systems, ion channel
technology, and robotic systems for high-throughput and low-cost screening services, Aurora Biomed Inc. is
researching novel technologies to expand and improve its products in response to the increased demand and
technical requirements of today's modern laboratories. Specifically, the VERSATM GENE is a bench-top
workstation equipped with advanced robotic features and high precision liquid handling capabilities designed
to perform nucleic acid purification and polymerase chain reaction (PCR) with high throughput and accuracy.
This system is capable of complete work-up of RNA or DNA samples from extraction to preparation of the
PCR plate for amplification, allowing researchers to overcome nucleic acid extraction bottlenecks. Since the advent of microfluidics research and its numerous successful applications, there has been an increased thrust towards microdevices as alternatives for bench-top scale equipment traditionally used for clinical and forensic diagnostics. The main drivers for this trend are miniaturization, reduced time and cost, high throughput, and greater reliability of results. The addition of a microscale DNA purification device into the product line will be a tremendous competitive edge for Aurora Biomed Inc. The proposed research will provide a proof-of-concept microfluidic prototype for DNA purification and separation. This research will involve the development of a microscale DNA extraction, purification and separation system. Specifically, a digital microfluidic device capable of handling and manipulation of sample droplets having volumes in the range of tens of picoliter to a few hundred nanoliter will be designed, fabricated and tested. This research will be a steppingstone towards long-term collaboration between Aurora Biomed and the applicant in the development of digital microfluidic systems for point-of-care diagnosis and drug discovery applications.